AAIC 2025 Abstract
Ultra‐Sensitive SPEAR Immunoassay with Cross‐Platform qPCR Consistency for Neurodegenerative Biomarker Measurement
Study in peopleBiomarkers
Abstract
Background: Neurodegenerative diseases such as Alzheimer's disease (AD) require highly sensitive and specific diagnostic tools for early detection and monitoring. Immunoassay‐based detection of disease‐associated biomarkers in biofluids shows promise but faces challenges in sensitivity, reproducibility, and scalability.
